Methyl N-[1-[2-[6-[6-[5-[2-[1-(2-amino-3-methylbutanoyl)pyrrolidin-2-yl]-1H-imidazol-5-yl]thiophen-2-yl]-11-oxatricyclo[6.2.1.02,7]undeca-1(10),2,4,6,8-pentaen-3-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
C44H48N8O5S — CID 123636936
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl N-[1-[2-[6-[6-[5-[2-[1-(2-amino-3-methylbutanoyl)pyrrolidin-2-yl]-1H-imidazol-5-yl]thiophen-2-yl]-11-oxatricyclo[6.2.1.02,7]undeca-1(10),2,4,6,8-pentaen-3-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
Methyl N-[1-[2-[6-[6-[5-[2-[1-(2-amino-3-methylbutanoyl)pyrrolidin-2-yl]-1H-imidazol-5-yl]thiophen-2-yl]-11-oxatricyclo[6.2.1.02,7]undeca-1(10),2,4,6,8-pentaen-3-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate (PubChem CID 123636936) has the molecular formula C44H48N8O5S and a molecular weight of 800.99 g/mol. Its IUPAC name is methyl N-[1-[2-[6-[6-[5-[2-[1-(2-amino-3-methylbutanoyl)pyrrolidin-2-yl]-1H-imidazol-5-yl]thiophen-2-yl]-11-oxatricyclo[6.2.1.02,7]undeca-1(10),2,4,6,8-pentaen-3-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate.
Molecular Properties
| Compound Name | Methyl N-[1-[2-[6-[6-[5-[2-[1-(2-amino-3-methylbutanoyl)pyrrolidin-2-yl]-1H-imidazol-5-yl]thiophen-2-yl]-11-oxatricyclo[6.2.1.02,7]undeca-1(10),2,4,6,8-pentaen-3-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate |
|---|---|
| PubChem CID | 123636936 |
| Molecular Formula | C44H48N8O5S |
| Molecular Weight | 800.99 g/mol |
| Exact Mass | 800.35 |
| IUPAC Name | methyl N-[1-[2-[6-[6-[5-[2-[1-(2-amino-3-methylbutanoyl)pyrrolidin-2-yl]-1H-imidazol-5-yl]thiophen-2-yl]-11-oxatricyclo[6.2.1.02,7]undeca-1(10),2,4,6,8-pentaen-3-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate |
| SMILES | COC(=O)NC(C(=O)N1CCCC1c1nc2ccc(-c3ccc(-c4ccc(-c5cnc(C6CCCN6C(=O)C(N)C(C)C)[nH]5)s4)c4c5ccc(o5)c34)cc2[nH]1)C(C)C |
| InChI | InChI=1S/C44H48N8O5S/c1-22(2)38(45)42(53)51-18-6-8-30(51)40-46-21-29(49-40)35-17-16-34(58-35)26-12-11-25(36-32-14-15-33(57-32)37(26)36)24-10-13-27-28(20-24)48-41(47-27)31-9-7-19-52(31)43(54)39(23(3)4)50-44(55)56-5/h10-17,20-23,30-31,38-39H,6-9,18-19,45H2,1-5H3,(H,46,49)(H,47,48)(H,50,55) |
| InChIKey | VAYRVJNVHKGXJT-UHFFFAOYSA-N |
| XLogP | 8.38 |
| TPSA | 175.47 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 58 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 800.99 |
| LogP ≤ 5 | 8.38 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123636936 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.